AstraZeneca Applies for Approval in The EU
The pharmaceutical company AstraZeneca applies for approval of its Covid-19 vaccine in the EU. The responsible authority EMA announced that they want to make a decision by the end of January.
The British-Swedish pharmaceutical company AstraZeneca has applied for approval of its corona vaccine in the European Union. The European Medicines Agency (EMA) in Amsterdam announced that a decision on the application for conditional marketing authorization could probably be made by the end of January. The evaluation of the vaccine will take place “in an accelerated time frame”. It has so far approved the vaccines from Biontech / Pfizer and the US company Moderna for the European market.
At the end of December, Great Britain became the first country in the world to give the green light for the vaccine that AstraZeneca had developed with Oxford University. People there have been vaccinated with it for a week.
The vector virus vaccine is slightly less effective than the novel mRNA agents from Biontech / Pfizer and Moderna. But it is easier to use because it can be stored at normal refrigerator temperatures. At two euros per dose, the vaccine is also significantly cheaper than the other preparations previously approved in the EU. According to information accidentally published by a Belgian government official, the Moderna drug is the most expensive at 18 dollars (14.66 euros) per dose. The vaccine from Biontech and Pfizer is therefore twelve euros per dose. The EU has ordered 400 million doses of the AstraZeneca vaccine.
In Germany, more than 600,000 people have been vaccinated so far, in Great Britain it was four times as many. Therefore, a debate about a possible vaccination has broken out.
AstraZeneca Applies for Approval in The EU
You may also like:
Another Corona Variant Found in Japan
